Actemra 160mg, a drug known scientifically as tocilizumab, represents a potent biologic agent primarily utilized for the treatment of rheumatoid arthritis. This remarkable agent acts by interfering with the activity of interleukin-6 (IL-6), a regulatory protein essential in the inflammatory process. Additionally, Actemra has shown effectiveness in